Rare diseases
Investigational molecules
Locations
Building 2 13th Floor, No. 36 And 58 Haiqu Road, Pudong New Area, 201203
Clinical research in limited-stage small cell lung cancer focuses on patients without disease progression after chemoradiotherapy, with interest in consolidation therapy and survival outcomes such as overall survival and progression-free survival.
Research activities in this area include immunotherapy-based combinations for post-chemoradiotherapy disease control.
Shanghai Junshi Biosciences Co. Ltd. runs clinical trials in conditions such as Small cell lung cancer limited stage, Hepatocellular carcinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
